Philippe Poirier

Philippe Poirier

Auto-generated profile, based on publicly available information

Philippe Poirier

Service de Parasitologie-Mycologie, CHU Clermont-Ferrand, 3iHP, 63000 Clermont-Ferrand, France

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2016 in Scientific Reports
Verified
Journal Article
Open access
CAChristophe Audebert
Christophe Audebert
GEGaël Even
Gaël Even
ACAmandine Cian
Amandine Cian
TGThe Blastocystis Investigation Group
The Blastocystis Investigation Group
DSDima El Safadi
Dima El Safadi
Magali ChabéMagali Chabé
Magali Chabé
Alterations in the composition of commensal bacterial populations, a phenomenon known as dysbiosis, are linked to multiple gastrointestinal disorders, such as inflammatory bowel disease and irritable bowel syndrome, or to infections by diverse enteric pathogens. Blastocystis is one of the most common single-celled eukaryotes detected in human faecal samples. However, the clinical significance of this widespread colonization remains unclear, and its pathogenic potential is controversial. To address the issue of Blastocystis pathogenicity, we investigated the impact of colonization by this protist on the composition of the human gut microbiota. For that purpose, we conducted a cross-sectional study including 48 Blastocystis-colonized patients and 48 Blastocystis-free subjects and performed an Ion Torrent 16S rDNA gene sequencing to decipher the Blastocystis-associated gut microbiota. Here, we report a higher bacterial diversity in faecal microbiota of Blastocystis colonized patients, a higher abundance of Clostridia as well as a lower abundance of Enterobacteriaceae. Our results contribute to suggesting that Blastocystis colonization is usually associated with a healthy gut microbiota, rather than with gut dysbiosis generally observed in metabolic or infectious inflammatory diseases of the lower gastrointestinal tract.

25 March 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DSDima El Safadi
Dima El Safadi
LGLobna Gaayeb
Lobna Gaayeb
DMDionigia Meloni
Dionigia Meloni
ACAmandine Cian
Amandine Cian
PPPhilippe Poirier
Philippe Poirier
Eric ViscogliosiEric Viscogliosi
Eric Viscogliosi
Blastocystis sp. is currently the most common intestinal protist found in human feces and considered an emerging parasite with a worldwide distribution. Because of its potential impact in public health, we reinforced the picture of Blastocystis sp. prevalence and molecular subtype distribution in Africa by performing the first survey of this parasite in Senegal.

1 September 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
LMLaurence Millon
Laurence Millon
RHRaoul Herbrecht
Raoul Herbrecht
FGFrederic Grenouillet
Frederic Grenouillet
FMF. Morio
F. Morio
AAA. Alanio
A. Alanio
DHD. Hoinard
D. Hoinard

12 September 2013 in Therapeutic Advances in Infectious Disease
Verified
Journal Article
Open access
PDF file
IWIvan Wawrzyniak
Ivan Wawrzyniak
PPPhilippe Poirier
Philippe Poirier
Eric ViscogliosiEric Viscogliosi
Eric Viscogliosi
MDMeloni Dionigia
Meloni Dionigia
CTCatherine Texier
Catherine Texier
HAHicham El Alaoui
Hicham El Alaoui
Blastocystis sp. is among the few enteric parasites with a prevalence that often exceeds 5% in the general population of industrialized countries and can reach 30–60% in developing countries. This parasite is frequently found in people who are immunocompromised (patients with human immunodeficiency virus/acquired immunodeficiency syndrome or cancer) and a higher risk of Blastocystis sp. infection has been found in people with close animal contact. Such prevalence in the human population and the zoonotic potential naturally raise questions about the impact of these parasites on public health and has increased interest in this area. Recent in vitro and in vivo studies have shed new light on the pathogenic power of this parasite, suggesting that Blastocystis sp. infection is associated with a variety of gastrointestinal disorders, may play a significant role in irritable bowel syndrome, and may be linked with cutaneous lesions (urticaria). Despite recent significant advances in the knowledge of the extensive genetic diversity of this species, the identification of extracellular proteases as virulence factors and the publication of one isolate genome, many aspects of the biology of Blastocystis sp. remain poorly investigated. In this review, we investigate several biological aspects of Blastocystis sp. (diversity and epidemiology, diagnosis tools and pathophysiology). These data pave the way for the following challenges concerning Blastocystis sp. research: deciphering key biological mechanisms and pathways of this parasite and clarification of its clinical impact in humans.

15 March 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
PPPhilippe Poirier
Philippe Poirier
IWIvan Wawrzyniak
Ivan Wawrzyniak
CVChristian P. Vivarès
Christian P. Vivarès
FDFrédéric Delbac
Frédéric Delbac
HAHicham El Alaoui
Hicham El Alaoui
International audienceBlastocystis spp. belong to the phylum Stramenopila, a complex and heterogeneous evolutionary assemblage of heterotrophic and photosynthetic protozoa [1]. Interestingly, this is the only stramenopile living in the lower digestive tract of humans, and it also lives in other mammals, birds, reptiles, amphibians, and insects [1]. Even though isolates were reported to be morphologically indistinguishable, an extensive genetic variation among isolates from both humans and animals has been observed. Thirteen subtypes (ST1-ST13), with the first nine being found in humans, have been identified based on genes coding for the small-subunit ribosomal RNA [2]. Preferential repartition of STs exists among animals that appear to constitute the main reservoir for environmental dissemination and human contamination

1 March 2011 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PPPhilippe Poirier
Philippe Poirier
IWIvan Wawrzyniak
Ivan Wawrzyniak
AAAurélie Albert
Aurélie Albert
HAHicham El Alaoui
Hicham El Alaoui
FDFrédéric Delbac
Frédéric Delbac
VLValérie Livrelli
Valérie Livrelli
Blastocystis anaerobic parasites are widespread worldwide in the digestive tract of many animal species, including humans. Epidemiological Blastocystis studies are often limited by the poor sensitivity of standard parasitological assays for its detection. This report presents a highly sensitive real-time quantitative PCR (qPCR) assay developed to detect Blastocystis parasites in stool samples. The assay targets a partial sequence of the Blastocystis small ribosomal subunit (SSU) rRNA gene, allowing subtyping (ST) of Blastocystis isolates by direct sequencing of qPCR products. This qPCR method was assessed in a prospective study of 186 patients belonging to two cohorts—a group of 94 immunocompromised patients presenting hematological malignancies and a control group of 92 nonimmunocompromised patients. Direct-light microscopy and xenic in vitro stool culture analysis showed only 29% and 52% sensitivity, respectively, compared to our qPCR assay. Of the 27 (14.5%) Blastocystis -positive patients, 8 (4%) experienced digestive symptoms. No correlation was found between symptomatic patients and immune status, parasite load, or parasite subtypes, although subtyping of all isolates revealed a high (63.0%) prevalence of ST4. Two unexpected avian subtypes were found, i.e., ST6 and ST7, which are frequently isolated in Asia but rarely present in Western countries. In conclusion, this qPCR proved by far the most sensitive of the tested methods and allowed subtype determination by direct sequencing of qPCR products. New diagnostic tools such as the qPCR are essential for evaluating the clinical relevance of Blastocystis subtypes and their role in acute or chronic digestive disorders.